Navigation Links
Health IT Leaders Discuss Road to Clinical Transformation with BYOD
Date:2/4/2013

SALEM, N.H., Feb. 4, 2013 /PRNewswire/ -- Enterasys Networks, a Siemens Enterprise Communications Company, will participate in a webinar for HIMSS members on the role BYOD will play in enabling clinical transformation, hosted by Gregg Malkary , Managing Director of Spyglass Consulting Group. As physicians are demanding to use their own personal devices in hospitals, it is becoming increasingly important for health IT professionals to ensure they can offer this to their employees and keep sensitive data secure on hospital Wi-Fi. A panel of leading health IT experts will discuss how BYOD can transform the delivery of healthcare while keeping sensitive patient data safe and secure.WHAT:BYOD Enables Clinical Transformation – A Health IT Leader Panel Conversation WHEN:Monday, February 11, 2013 from 2:00pm-3:00pm ETWHO:

  • Gregg Malkary, Managing Director, Spyglass Consulting Group
  • Christopher Kunney, CPHIT, MSMOT
    President-Elect, Georgia HIMSS Chapter
    (Georgia HIMSS is Chapter of the Year)
    Emerging Healthcare IT Strategist-The BAE Company
  • Philip Joy, Technical Services Manager, Bryan Health, @Bryan_Health
  • Konnie Jacks, Network Manager, Memorial Hospital of West Texas
  • Moderator: Christopher Kunney, Executive Healthcare IT Strategist, Georgia HIMSS, @HeathcareITProf
  • Tamera Rousseau-Vesta, Healthcare Solutions Marketing Manager, Enterasys Networks, @tameraRV
  • TOPICS:How BYOD is changing the face of healthcare delivery,What important issues need to be addressed before adopting a BYOD strategy, andHow clinical transformation can be achieved by embracing physician mobilityTO REGISTER:Please note, HIMSS members
    '/>"/>
    SOURCE Enterasys Networks, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related medicine technology :

    1. Wacoms DTH-2242: An Ideal Interactive Pen and Touch Display Solution for Healthcare and Presentation Markets
    2. Solta Medical to Present at the Leerink Swann Global Healthcare Conference in New York on February 14, 2013
    3. Perrigo Company To Acquire OTC Companion Animal Health Company, Velcera, Inc., For $160 Million
    4. Luminex Corporation To Present At Leerink Swann Global Healthcare Conference
    5. InternetArray Collaborates with Health Sciences Group to Fund Medical Marijuana Social Media/Mobile Apps Development
    6. Allina Health and Childrens Hospitals and Clinics of Minnesota Celebrate Grand Opening of The Mother Baby Center
    7. Fight Erectile Dysfunction the Safe and Healthy Way with Function for Men
    8. Home Access Health Corp. encourages cholesterol testing during American Heart Month, beyond
    9. PharmaNet/i3 Renamed inVentiv Health Clinical
    10. The Female Health Company Reports Record First Quarter FY2013 Operating Results
    11. Genomic Health to Announce Fourth Quarter and Year-End 2012 Financial Results and Host Conference Call on Wednesday, February 6, 2013
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/29/2015)... 29, 2015 Asterias Biotherapeutics, Inc. (NYSE MKT: ... of regenerative medicine, today announced that it will release ... 10, 2015 after the close of the U.S. financial ... webcast on Monday, August 10, 2015 at 4:30 p.m. ... and corporate developments. For both "listen-only" participants ...
    (Date:7/29/2015)... 29, 2015  Depomed, Inc. (NASDAQ: DEPO ) ... Board of Directors, after careful consideration and with ... advisors, has unanimously rejected the purported revised, highly ... plc (NASDAQ: HZNP ) ("Horizon") to acquire ... an all-stock transaction (the "July 21 Proposal"). ...
    (Date:7/29/2015)... 29, 2015 Immune Pharmaceuticals Inc. (NASDAQ: IMNP ... up to $21.5 million through two financing agreements. The ... ) ("Hercules"), for a term loan of up to ... Growth Fund ("Discover"), for the sale to Discover of ... Stock") for up to $12 million in gross proceeds ...
    Breaking Medicine Technology:Asterias Biotherapeutics to Report Second Quarter Results on August 10, 2015 2Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 2Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 3Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 4Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 5Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditio